These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 25023206)
1. Psychiatric morbidity in ketamine users attending counselling and youth outreach services. Tang WK; Morgan CJ; Lau GC; Liang HJ; Tang A; Ungvari GS Subst Abus; 2015; 36(1):67-74. PubMed ID: 25023206 [TBL] [Abstract][Full Text] [Related]
2. Psychiatric disorders and association with quality of sleep and quality of life in patients with chronic pain: a SCID-based study. Annagür BB; Uguz F; Apiliogullari S; Kara I; Gunduz S Pain Med; 2014 May; 15(5):772-81. PubMed ID: 24612225 [TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Lugnegård T; Hallerbäck MU; Gillberg C Res Dev Disabil; 2011; 32(5):1910-7. PubMed ID: 21515028 [TBL] [Abstract][Full Text] [Related]
4. Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users. Fan N; Xu K; Ning Y; Rosenheck R; Wang D; Ke X; Ding Y; Sun B; Zhou C; Deng X; Tang W; He H Psychiatry Res; 2016 Mar; 237():311-5. PubMed ID: 26805565 [TBL] [Abstract][Full Text] [Related]
5. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887 [TBL] [Abstract][Full Text] [Related]
6. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Sharifi V; Amin-Esmaeili M; Hajebi A; Motevalian A; Radgoodarzi R; Hefazi M; Rahimi-Movaghar A Arch Iran Med; 2015 Feb; 18(2):76-84. PubMed ID: 25644794 [TBL] [Abstract][Full Text] [Related]
8. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728 [TBL] [Abstract][Full Text] [Related]
9. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China. Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246 [TBL] [Abstract][Full Text] [Related]
10. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445 [TBL] [Abstract][Full Text] [Related]
13. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J; Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922 [TBL] [Abstract][Full Text] [Related]
14. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Gum AM; King-Kallimanis B; Kohn R Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949 [TBL] [Abstract][Full Text] [Related]
16. Correlates of psychiatric co-morbidity in a sample of Egyptian patients with bipolar disorder. Asaad T; Okasha T; Ramy H; Fekry M; Zaki N; Azzam H; Rabie MA; Elghoneimy S; Sultan M; Hamed H; Refaat O; Shorab I; Elhabiby M; Elgweily T; ElShinnawy H; Nasr M; Fathy H; Meguid MA; Nader D; Elserafi D; Enaba D; Ibrahim D; Elmissiry M; Mohsen N; Ahmed S J Affect Disord; 2014 Sep; 166():347-52. PubMed ID: 24981131 [TBL] [Abstract][Full Text] [Related]
17. Patterns and predictors of comorbidity of DSM-IV anxiety disorders in a clinical sample of children and adolescents. Leyfer O; Gallo KP; Cooper-Vince C; Pincus DB J Anxiety Disord; 2013 Apr; 27(3):306-11. PubMed ID: 23602944 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of dual diagnosis among clinic attending patients in a de-addiction centre of a tertiary care hospital. Subodh BN; Hazari N; Elwadhi D; Basu D Asian J Psychiatr; 2017 Feb; 25():169-174. PubMed ID: 28262143 [TBL] [Abstract][Full Text] [Related]
20. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]